Literature DB >> 9027850

Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy.

E Mercuri1, J Pennock, F Goodwin, C Sewry, F Cowan, L Dubowitz, V Dubowitz, F Muntoni.   

Abstract

Diffuse white matter changes on brain imaging and peripheral neuropathy are associated features of merosin-deficient congenital muscular dystrophy (CMD). In this report we describe the early manifestation and evolution of brain changes, and the involvement of the peripheral nervous system in a female infant with merosin-deficient CMD diagnosed in the neonatal period who had sequential clinical, neurophysiological and magnetic resonance imaging (MRI) assessment. Both MRI and nerve conduction velocity in the first week of life failed to demonstrate any abnormality. By 6 months of age both nerve conduction and MRI were abnormal. White matter changes became more evident on a further scan at 1 yr of age and this pattern remained unchanged on the following scan performed at 17 months of age. Our findings suggest a failure in the physiological maturation process of myelination of both the central and peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027850     DOI: 10.1016/s0960-8966(96)00383-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  Gpr126/Adgrg6 Has Schwann Cell Autonomous and Nonautonomous Functions in Peripheral Nerve Injury and Repair.

Authors:  Amit Mogha; Breanne L Harty; Dan Carlin; Jessica Joseph; Nicholas E Sanchez; Ueli Suter; Xianhua Piao; Valeria Cavalli; Kelly R Monk
Journal:  J Neurosci       Date:  2016-12-07       Impact factor: 6.167

Review 2.  How Schwann Cells Sort Axons: New Concepts.

Authors:  M Laura Feltri; Yannick Poitelon; Stefano Carlo Previtali
Journal:  Neuroscientist       Date:  2015-02-16       Impact factor: 7.519

3.  PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy.

Authors:  P Guicheney; N Vignier; X Zhang; Y He; C Cruaud; V Frey; A Helbling-Leclerc; P Richard; B Estournet; L Merlini; H Topaloglu; M Mora; J P Harpey; C A Haenggeli; A Barois; B Hainque; K Schwartz; F M Tomé; M Fardeau; K Tryggvason
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

Review 4.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

Review 5.  Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.

Authors:  Peter D Yurchenco; Karen K McKee; Judith R Reinhard; Markus A Rüegg
Journal:  Matrix Biol       Date:  2017-11-27       Impact factor: 11.583

Review 6.  New insights on Schwann cell development.

Authors:  Kelly R Monk; M Laura Feltri; Carla Taveggia
Journal:  Glia       Date:  2015-04-29       Impact factor: 7.452

7.  Cobblestone Malformation in LAMA2 Congenital Muscular Dystrophy (MDC1A).

Authors:  Himali Jayakody; Sanam Zarei; Huy Nguyen; Joline Dalton; Kelly Chen; Louanne Hudgins; John Day; Kara Withrow; Arti Pandya; Jean Teasley; William B Dobyns; Katherine D Mathews; Steven A Moore
Journal:  J Neuropathol Exp Neurol       Date:  2020-09-01       Impact factor: 3.685

8.  Jab1 regulates Schwann cell proliferation and axonal sorting through p27.

Authors:  Emanuela Porrello; Cristina Rivellini; Giorgia Dina; Daniela Triolo; Ubaldo Del Carro; Daniela Ungaro; Martina Panattoni; Maria Laura Feltri; Lawrence Wrabetz; Ruggero Pardi; Angelo Quattrini; Stefano Carlo Previtali
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.